Abstract:Pharmaceutical evaluations of nanomedicines are of great significance for their further launch into industry and clinic. Near-infrared (NIR) fluorescence imaging plays essential roles in preclinical drug development by providing important insights into the biodistributions of drugs in vivo with deep tissue penetration and high spatiotemporal resolution. However, NIR-II fluorescence imaging has rarely been exploited for in vivo real-time pharmaceutical evaluations of nanomedicine. Herein, we developed a highly emissive NIR-II luminophore to establish a versatile nanoplatform to noninvasively monitor the in vivo metabolism of nanomedicines bound various polyethylene glycol (PEG) ligands in a real-time manner. An alternative D–A–D conjugated oligomer (DTTB) was synthesized to achieve NIR-II emission peaked at ∼1050 nm with high fluorescence QYs of 13.4% and a large absorption coefficient. By anchoring with the DTTB molecule, intrinsically fluorescent micelles were fabricated and bound with PEG ligands at various chain lengths. In vivo NIR-II fluorescence and photoacoustic imaging results revealed that an appropriate PEG chain length could effectively contribute to the longer blood circulation and better tumor targeting. In vivo therapeutic experiments also confirmed the optimized nanomedicines have efficient photothermal elimination of tumors and good biosafety. This work offered an alternative highly fluorescent NIR-II material and demonstrated a promising approach for real-time pharmaceutical evaluation of nanomedicine in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05885?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05885</a>.Additional experimental methods, the synthetic route to DTTB, NMR spectra of DTTB, HRMS spectra of DTTB, UV–vis–NIR spectra and emission spectra of DTTB, TEM image of and NMs, PA imaging stability test of ICG and solution, ex vivo NIR-II fluorescence imaging of major organs, photothermal properties tests of , photothermal ablation efficiency assessment of in vitro, and hemolysis analysis of (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_001.pdf">PDF</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_002.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_003.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_004.avi">AVI</a>)This article has not yet been cited by other publications.

Real-time in Vivo Visualization of Tumor Therapy by a Near-Infrared-ii Ag 2 S Quantum Dot-Based Theranostic Nanoplatform

A Novel TMTP1-modified Theranostic Nanoplatform for Targeted in Vivo NIR-II Fluorescence Imaging-guided Chemotherapy of Cervical Cancer

An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.

In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene- and Photothermal Therapy.

NIR-II Fluorescent Activatable Drug Delivery Nanoplatform for Cancer-Targeted Combined Photodynamic and Chemotherapy

Characterization of Tumor-Targeting Ag2S Quantum Dots for Cancer Imaging and Therapy in Vivo.

A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.

Functionalized Near-Infrared Quantum Dots For In Vivo Tumor Vasculature Imaging

In Vivo Real-Time Visualization of Tissue Blood Flow and Angiogenesis Using Ag2S Quantum Dots in the NIR-II Window.

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation

Functional Nanorealgar Quantum Dots with Aggregation-Induced Emission Enhancement for Tumor Neovascular-Targeted Theranostics

NIR‐II Ratiometric Fluorescent Nanoplatform for Real‐Time Monitoring and Evaluating Cancer Sonodynamic Therapy Efficacy

In Vivo Cancer Targeting and Imaging-Guided Surgery with Near Infrared-Emitting Quantum Dot Bioconjugates

A near-infrared light-responsive extracellular vesicle as a “Trojan horse” for tumor deep penetration and imaging-guided therapy

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

In Vivo Cancer Targeting and Fluorescence-Ct Dual-Mode Imaging with Nanoprobes Based on Silver Sulfide Quantum Dots and Iodinated Oil

Integrated Prodrug Micelles with Two-Photon Bioimaging and Ph-Triggered Drug Delivery for Cancer Theranostics

Programmable Chemotherapy and Immunotherapy against Breast Cancer Guided by Multiplexed Fluorescence Imaging in the Second Near-Infrared Window.

Two-photon AIE Probe Conjugated Theranostic Nanoparticles for Tumor Bioimaging and Ph-Sensitive Drug Delivery

Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature-Targeted Strategy

SERS/NIR‐II Optical Nanoprobes for Multidimensional Tumor Imaging from Living Subjects, Pathology, and Single Cells and Guided NIR‐II Photothermal Therapy